Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029704 (2-(4-Benzyl-5-oxo-2,5-dihydro-furan-3-yloxymethyl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.0130 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029709 (2-(4-Benzyl-2-methyl-5-oxo-2,5-dihydro-furan-3-ylo...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.0160 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029710 (4-Isopropyl-6-methoxy-2-(2-methyl-5-oxo-4-phenyl-2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.0210 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029699 (2,6-Dichloro-benzoic acid 4-isopropyl-6-methoxy-1,...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.0230 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029717 (2-(3-Chloro-6-methyl-2-oxo-2H-pyran-4-yloxymethyl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.0250 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029698 (4-Isopropyl-6-methoxy-1,1-dioxo-2-(5-oxo-4-phenyl-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.0250 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029696 (2-(3-Benzoyl-6-methyl-2-oxo-2H-pyran-4-yloxymethyl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.0270 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029712 (2-(4-Chloro-5-oxo-2,5-dihydro-furan-3-yloxymethyl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.0300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029713 (4-Isopropyl-6-methoxy-1,1-dioxo-2-(3-oxo-cyclobut-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.0330 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029691 (2-(2-Benzyl-3-oxo-cyclopent-1-enyloxymethyl)-4-iso...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.0340 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029692 (4-Isopropyl-6-methoxy-2-(6-methyl-2-oxo-2H-pyran-4...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.0500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029695 (4-Isopropyl-6-methoxy-1,1-dioxo-2-(5-oxo-2,5-dihyd...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.0520 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029711 (3-Bromo-2-(4-isopropyl-6-methoxy-1,1,3-trioxo-1,3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.0580 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029720 (4-Isopropyl-6-methoxy-2-(2-methyl-3-oxo-cyclopent-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.0600 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029707 (3-Chloro-2-(4-isopropyl-6-methoxy-1,1,3-trioxo-1,3...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.0660 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029721 (2-(4-Isopropyl-6-methoxy-1,1,3-trioxo-1,3-dihydro-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.0780 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029715 (4-Isopropyl-6-methoxy-1,1-dioxo-2-(3-oxo-3H-inden-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.0830 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029718 (4-Isopropyl-6-methoxy-1,1-dioxo-2-(2-oxo-2H-chrome...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.0900 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029700 (4-Isopropyl-6-methoxy-2-(2-methyl-5-oxo-2,5-dihydr...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.0930 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029706 (2-(4-Isopropyl-6-methoxy-1,1,3-trioxo-1,3-dihydro-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | PubMed | 0.110 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029716 (2-(1-Benzyl-5-oxo-2,5-dihydro-1H-pyrrol-3-yloxymet...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.140 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029708 (4-Isopropyl-6-methoxy-2-(2-methyl-3-oxo-cyclohex-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.180 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029702 (3-Chloro-2-(4-isopropyl-1,1,3-trioxo-1,3-dihydro-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.210 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029693 (4-Isopropyl-6-methoxy-1,1-dioxo-2-(2-oxo-2H-thioch...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.220 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029714 (2-(4-Isopropyl-6-methoxy-1,1,3-trioxo-1,3-dihydro-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.25 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029703 (4-Isopropyl-6-methoxy-1,1-dioxo-2-(1-phenyl-1H-tet...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.270 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029705 (4-(4-Isopropyl-6-methoxy-1,1,3-trioxo-1,3-dihydro-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029694 (2-(4-sec-Butyl-1,1,3-trioxo-1,3-dihydro-1lambda*6*...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.720 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029719 (2-(1,6-Dimethyl-2-oxo-1,2-dihydro-pyridin-4-yloxym...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.850 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029701 (3-Benzyl-2-(4-isopropyl-6-methoxy-1,1,3-trioxo-1,3...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 0.900 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neutrophil elastase (Homo sapiens (Human)) | BDBM50029697 (3-Chloro-2-(1,1,3-trioxo-1,3-dihydro-1lambda*6*-be...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 14 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sterling Winthrop Pharmaceuticals Research Division Curated by ChEMBL | Assay Description Potency of inhibition of human leukocyte elastase is expressed as apparent binding constant | J Med Chem 38: 4687-92 (1995) BindingDB Entry DOI: 10.7270/Q2KP816X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Rattus norvegicus (rat)) | BDBM50032599 ((4-Methoxy-naphthalen-1-yl)-[1-(2-morpholin-4-yl-e...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Research Division Curated by ChEMBL | Assay Description Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes. | J Med Chem 38: 3094-105 (1995) BindingDB Entry DOI: 10.7270/Q2DN442Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Rattus norvegicus (rat)) | BDBM50032565 ((4-Methyl-naphthalen-1-yl)-[1-(2-morpholin-4-yl-et...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Research Division Curated by ChEMBL | Assay Description Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes. | J Med Chem 38: 3094-105 (1995) BindingDB Entry DOI: 10.7270/Q2DN442Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Rattus norvegicus (rat)) | BDBM50032584 ((4-Hydroxy-naphthalen-1-yl)-[1-(2-morpholin-4-yl-e...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 3.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Research Division Curated by ChEMBL | Assay Description Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes. | J Med Chem 38: 3094-105 (1995) BindingDB Entry DOI: 10.7270/Q2DN442Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Rattus norvegicus (rat)) | BDBM50032615 (CHEMBL82361 | [6-Methyl-1-(2-morpholin-4-yl-ethyl)...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 3.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Research Division Curated by ChEMBL | Assay Description Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes. | J Med Chem 38: 3094-105 (1995) BindingDB Entry DOI: 10.7270/Q2DN442Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Rattus norvegicus (rat)) | BDBM60994 ((10R,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tet...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL DrugBank KEGG PC cid PC sid PDB UniChem Similars | PubMed | n/a | n/a | 5.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Research Division Curated by ChEMBL | Assay Description Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes. | J Med Chem 38: 3094-105 (1995) BindingDB Entry DOI: 10.7270/Q2DN442Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Rattus norvegicus (rat)) | BDBM50032575 (CHEMBL309763 | [2-Methyl-1-(2-morpholin-4-yl-ethyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 5.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Research Division Curated by ChEMBL | Assay Description Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes. | J Med Chem 38: 3094-105 (1995) BindingDB Entry DOI: 10.7270/Q2DN442Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Rattus norvegicus (rat)) | BDBM50032583 ((4-Bromo-naphthalen-1-yl)-[2-methyl-1-(2-morpholin...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 6.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Research Division Curated by ChEMBL | Assay Description Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes. | J Med Chem 38: 3094-105 (1995) BindingDB Entry DOI: 10.7270/Q2DN442Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Rattus norvegicus (rat)) | BDBM50009854 (CHEMBL13078 | [1-(2-Morpholin-4-yl-ethyl)-1H-indol...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 7.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Research Division Curated by ChEMBL | Assay Description Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes. | J Med Chem 38: 3094-105 (1995) BindingDB Entry DOI: 10.7270/Q2DN442Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Rattus norvegicus (rat)) | BDBM50032589 (CHEMBL78415 | [7-Methoxy-2-methyl-1-(2-morpholin-4...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Research Division Curated by ChEMBL | Assay Description Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes. | J Med Chem 38: 3094-105 (1995) BindingDB Entry DOI: 10.7270/Q2DN442Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Rattus norvegicus (rat)) | BDBM50032616 (CHEMBL78940 | [6-Bromo-2-methyl-1-(2-morpholin-4-y...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Research Division Curated by ChEMBL | Assay Description Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes. | J Med Chem 38: 3094-105 (1995) BindingDB Entry DOI: 10.7270/Q2DN442Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Rattus norvegicus (rat)) | BDBM50032621 (CHEMBL78713 | [2-Chloro-1-(2-morpholin-4-yl-ethyl)...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Research Division Curated by ChEMBL | Assay Description Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes. | J Med Chem 38: 3094-105 (1995) BindingDB Entry DOI: 10.7270/Q2DN442Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Rattus norvegicus (rat)) | BDBM50032560 (CHEMBL78994 | [2,6-Dimethyl-1-(2-morpholin-4-yl-et...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Research Division Curated by ChEMBL | Assay Description Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes. | J Med Chem 38: 3094-105 (1995) BindingDB Entry DOI: 10.7270/Q2DN442Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Rattus norvegicus (rat)) | BDBM50032561 (CHEMBL104841 | [2-Methyl-1-(1-methyl-2-morpholin-4...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Research Division Curated by ChEMBL | Assay Description Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes. | J Med Chem 38: 3094-105 (1995) BindingDB Entry DOI: 10.7270/Q2DN442Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Rattus norvegicus (rat)) | BDBM50032555 (4-[2-Methyl-1-(2-morpholin-4-yl-ethyl)-1H-indole-3...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Research Division Curated by ChEMBL | Assay Description Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes. | J Med Chem 38: 3094-105 (1995) BindingDB Entry DOI: 10.7270/Q2DN442Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Rattus norvegicus (rat)) | BDBM50032567 (Benzofuran-7-yl-[1-(2-morpholin-4-yl-ethyl)-1H-ind...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Research Division Curated by ChEMBL | Assay Description Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes. | J Med Chem 38: 3094-105 (1995) BindingDB Entry DOI: 10.7270/Q2DN442Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Rattus norvegicus (rat)) | BDBM50009864 (CHEMBL274833 | [2-Methyl-1-(2-morpholin-4-yl-ethyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Research Division Curated by ChEMBL | Assay Description Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes. | J Med Chem 38: 3094-105 (1995) BindingDB Entry DOI: 10.7270/Q2DN442Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Rattus norvegicus (rat)) | BDBM50032562 (Benzofuran-4-yl-[1-(2-morpholin-4-yl-ethyl)-1H-ind...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Research Division Curated by ChEMBL | Assay Description Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes. | J Med Chem 38: 3094-105 (1995) BindingDB Entry DOI: 10.7270/Q2DN442Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Rattus norvegicus (rat)) | BDBM50032595 (CHEMBL107106 | [1-(1-Methyl-2-morpholin-4-yl-ethyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 33 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Research Division Curated by ChEMBL | Assay Description Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes. | J Med Chem 38: 3094-105 (1995) BindingDB Entry DOI: 10.7270/Q2DN442Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Rattus norvegicus (rat)) | BDBM50032595 (CHEMBL107106 | [1-(1-Methyl-2-morpholin-4-yl-ethyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 33 | n/a | n/a | n/a | n/a | n/a | n/a |
Sanofi Research Division Curated by ChEMBL | Assay Description Concentration of compound required to inhibit 50% of [3H]-WIN- 55212 binding to Cannabinoid receptor 1 in rat cerebellum membranes. | J Med Chem 38: 3094-105 (1995) BindingDB Entry DOI: 10.7270/Q2DN442Z | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 97 total ) | Next | Last >> |